What is the recommended dosing schedule for Junel Fe (norgestimate/ethinyl estradiol with iron)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Junel Fe Dosing Schedule

Junel Fe should be taken as one tablet daily at the same time each day for 21 consecutive days of active hormonal tablets, followed by 7 days of iron-containing (ferrous fumarate) tablets, creating a continuous 28-day regimen with no pill-free days. 1

Standard Dosing Regimen

Junel Fe is available as a 28-day pack containing:

  • 21 active tablets (light yellow or pink) containing norethindrone acetate and ethinyl estradiol
  • 7 brown tablets containing 75 mg ferrous fumarate (non-hormonal, for ease of administration)

The ferrous fumarate tablets serve no therapeutic contraceptive purpose but maintain the daily pill-taking routine during the hormone-free interval 1.

Starting Options

You have two initiation methods:

Sunday-Start Regimen

  • Begin the first active tablet on the first Sunday after menstrual flow begins
  • If menstrual flow begins on Sunday, start that same day
  • Use backup contraception for the first 7 days 1
  • All subsequent cycles will start on Sunday

Day-1 Start Regimen

  • Begin the first active tablet on Day 1 of menstrual flow
  • Apply the appropriate day label strip over preprinted days on the dispenser
  • All subsequent cycles start on the same day of the week

Administration Guidelines

  • Take tablets at the same time daily, preferably with a meal or at bedtime 1
  • Strict adherence is essential for contraceptive efficacy 1
  • After completing all 21 active tablets, immediately begin the 7 iron tablets without interruption
  • Start the next pack immediately after finishing the iron tablets—there are no "off-tablet" days 1

Missed Dose Management

The CDC guidelines provide clear algorithms for missed pills 2:

One pill late (<24 hours):

  • Take as soon as possible
  • No backup contraception needed

One pill missed (24-48 hours):

  • Take the most recent missed pill immediately (discard others)
  • Continue regular schedule
  • Use backup contraception for 7 days
  • Consider emergency contraception if missed in Week 1 with recent unprotected intercourse

Two or more pills missed (≥48 hours):

  • Take most recent missed pill (discard others)
  • Use backup contraception for 7 days
  • If missed in Week 3: Skip the iron tablets and start a new pack immediately
  • Emergency contraception should be considered if missed in Week 1 with unprotected intercourse in previous 5 days 3, 2

Expected Bleeding Pattern

Menstruation typically begins 2-3 days after starting the iron tablets, though may occur as late as day 4-5 1. Breakthrough bleeding during active tablets should not prompt discontinuation—continue taking pills as scheduled 1.

Clinical Context

While the evidence provided discusses norgestimate formulations 3, Junel Fe contains norethindrone acetate, a different progestin. The general dosing principles for combined oral contraceptives remain consistent: 21 days of active hormones followed by a 7-day hormone-free (or iron-only) interval 3. The standard 28-day pack design optimizes adherence by eliminating the need to count days between cycles 1.

Related Questions

What is Estarylla (combined oral contraceptive containing ethinyl estradiol and norgestimate)?
What side effects should a patient on Sprintec (norgestimate/ethinyl estradiol) monitor?
What is the preferred birth control option between Larin Fe 1/20 (ethinyl estradiol and norethindrone), Tri-Estarylla (ethinyl estradiol and norgestimate), Tri-Linyah (ethinyl estradiol and norgestimate), and Tri-Lo-Marzia (ethinyl estradiol and norgestimate) for a healthy female of reproductive age with no contraindications to estrogen?
What treatment is recommended for a female with an intrauterine device (IUD) and hyperestrogenism presenting with acne?
Are Aurovela (norethindrone acetate/ethinyl estradiol) and Feirza similar oral contraceptive pills?
What is the recommended hormonal management for polycystic ovary syndrome, including first‑line and alternative therapy options?
In a 72-year-old patient with chronic obstructive pulmonary disease (COPD) who has frequent exacerbations and was hospitalized less than 24 hours ago after nebulized treatment, should he use albuterol (salbutamol) via metered‑dose inhaler or continue nebulized therapy for rescue, and what is the appropriate treatment for his cough?
What is the optimal combination therapy for an adult with hair‑dye‑induced hyperpigmentation and no contraindications (e.g., no melasma, active dermatitis, pregnancy, or hypersensitivity)?
In a 55-year-old man with newly diagnosed type 2 diabetes mellitus on metformin 1000 mg twice daily and a sulfonylurea (gliclazide or glyburide) for six months, with mildly elevated fasting plasma glucose and HbA1c within target, what is the appropriate next step in management?
What is the recommended proton pump inhibitor (PPI) dosing and duration for a 13-year-old child with gastro‑esophageal reflux disease, including erosive esophagitis?
What medication would be the best option for this patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.